Management of progressive multifocal leukoencephalopathy associated with natalizumab - possibilities and responsibility

被引：0
|
作者：
Holmoy, T. [1 ]
Hestvik, A. L. K.
Vartdal, F.
机构：
[1] Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway
[2] Ullevaal Univ Hosp, Dept Neurol, Oslo, Norway
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷 / 08期
关键词：
D O I：
10.1111/j.1468-1331.2006.01555.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E2 / E2
页数：1
相关论文
共 50 条
  • [41] Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
    Kinner, Markus
    Prehn, Christian
    Schneider, Ruth
    Schroeder, Christoph
    Kolb, Eva
    Gold, Ralf
    Hoepner, Robert
    Chan, Andew
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (03) : 921 - 927
  • [42] Determinants of clinical outcomes for patients with Natalizumab-associated progressive multifocal leukoencephalopathy
    Kappos, L.
    Mcguigan, C.
    Derfuss, T.
    Giovannoni, G.
    Oh, J.
    Ren, Z.
    McCarthy, K.
    Chang, I.
    Campbell, N.
    Ho, P. -R.
    Mason, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 19 - 20
  • [43] Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy
    Decard, Bernhard F.
    Haghikia, Aiden
    Toennes, Christina
    Thoene, Jan
    Lukas, Carsten
    Chan, Andrew
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) : 249 - 251
  • [44] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    G. Classen
    C. Classen
    C. Bernasconi
    C. Brandt
    R. Gold
    A. Chan
    R. Hoepner
    Journal of NeuroVirology, 2019, 25 : 133 - 136
  • [45] Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab
    Berger, JR
    Houff, S
    NEUROLOGICAL RESEARCH, 2006, 28 (03) : 299 - 305
  • [46] Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging
    Hodel, Jerome
    Outteryck, Olivier
    Dubron, Celine
    Dutouquet, Bastien
    Benadjaoud, Mohamed Amine
    Duhin, Emeline
    Verclytte, Sebastien
    Zins, Marc
    Luciani, Alain
    Rahmouni, Alain
    Pruvo, Jean-Pierre
    Vermersch, Patrick
    Leclerc, Xavier
    RADIOLOGY, 2016, 278 (03) : 863 - 872
  • [47] Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
    Yousry, TA
    Major, EO
    Ryschkewitsch, C
    Fahle, G
    Fischer, S
    Hou, J
    Curfman, B
    Miszkiel, K
    Mueller-Lenke, N
    Sanchez, E
    Barkhof, F
    Radue, EW
    Jager, HR
    Clifford, DB
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 924 - 933
  • [48] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY FROM NATALIZUMAB OR BRENTUXIMAB VEDOTIN
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2012, 112 (05) : 22 - 22
  • [49] Risk stratification of progressive multifocal leukoencephalopathy under natalizumab
    Warnke, C.
    Adams, O.
    Hartung, H. P.
    Gold, R.
    Hemmer, B.
    Hohlfeld, R.
    Stangel, M.
    Zipp, F.
    Wiendl, H.
    Kieseier, B. C.
    NERVENARZT, 2011, 82 (10): : 1314 - 1319
  • [50] Natalizumab: no further cases of progressive multifocal leukoencephalopathy reported
    Reactions Weekly, 2005, 1065 (1) : 2 - 2
12345